TL
Tirschwell & Loewy Portfolio holdings
AUM
$731M
This Quarter Return
+11.54%
1 Year Return
+15.45%
3 Year Return
+77.97%
5 Year Return
+97.59%
10 Year Return
–
AUM
$800M
AUM Growth
+$800M
(+6.3%)
Cap. Flow
-$30M
Cap. Flow
% of AUM
-3.75%
Top 10 Holdings %
Top 10 Hldgs %
45.05%
Holding
78
New
2
Increased
10
Reduced
41
Closed
7
Top Buys
| 1 |
NVRO
NEVRO CORP.
NVRO
|
$1.21M |
| 2 |
Brown-Forman Class B
BF.B
|
$986K |
| 3 |
Walt Disney
DIS
|
$724K |
| 4 |
Illinois Tool Works
ITW
|
$341K |
| 5 |
State Street
STT
|
$320K |
Top Sells
| 1 |
Dentsply Sirona
XRAY
|
$8.72M |
| 2 |
SPDR Euro Stoxx 50 ETF
FEZ
|
$4.45M |
| 3 |
Inogen
INGN
|
$2.35M |
| 4 |
Idexx Laboratories
IDXX
|
$1.9M |
| 5 |
Biogen
BIIB
|
$1.65M |
Sector Composition
| 1 | Healthcare | 47.62% |
| 2 | Technology | 10.62% |
| 3 | Industrials | 9.55% |
| 4 | Consumer Discretionary | 6.27% |
| 5 | Financials | 6.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
TIF
1
DELISTED
Tiffany & Co.
TIF
| $43.5M | 5.43% |
337,140
-3,050
| -0.9% | -$393K |
|
2
Cognex
CGNX
$7.3B
| $41.3M | 5.16% |
739,610
-2,065
| -0.3% | -$115K |
|
3
DexCom
DXCM
$29.3B
| $41M | 5.12% |
286,554
-3,650
| -1% | -$522K |
|
|
4
Inogen
INGN
$217M
| $37.7M | 4.71% |
154,495
-9,620
| -6% | -$2.35M |
|
|
5
Idexx Laboratories
IDXX
$51B
| $35.9M | 4.48% |
143,665
-7,615
| -5% | -$1.9M |
|
6
Mastercard
MA
$533B
| $34.6M | 4.32% |
155,341
-325
| -0.2% | -$72.3K |
|
|
ABMD
7
DELISTED
Abiomed Inc
ABMD
| $33.2M | 4.15% |
73,880
-60
| -0.1% | -$27K |
|
8
Insulet
PODD
$24.4B
| $31.5M | 3.94% |
297,580
-6,585
| -2% | -$698K |
|
9
Neogen
NEOG
$1.22B
| $31.4M | 3.92% |
438,417
-17,613
| -4% | -$1.26M |
|
10
Analog Devices
ADI
$121B
| $30.4M | 3.8% |
328,870
-3,975
| -1% | -$368K |
|
|
RTN
11
DELISTED
Raytheon Company
RTN
| $27.7M | 3.46% |
134,109
-30
| -0% | -$6.2K |
|
12
Johnson & Johnson
JNJ
$428B
| $27.1M | 3.39% |
196,050
-1,195
| -0.6% | -$165K |
|
13
Danaher
DHR
$145B
| $26.9M | 3.37% |
247,916
+1,415
| +0.6% | +$154K |
|
14
Honeywell
HON
$137B
| $26.4M | 3.3% |
158,859
-85
| -0.1% | -$14.1K |
|
|
15
Brown-Forman Class B
BF.B
$13.8B
| $26.3M | 3.28% |
519,874
+19,510
| +4% | +$986K |
|
|
16
Biogen
BIIB
$20.3B
| $23.6M | 2.94% |
66,683
-4,674
| -7% | -$1.65M |
|
17
Ross Stores
ROST
$48.8B
| $21.5M | 2.69% |
217,029
-2,730
| -1% | -$271K |
|
18
Novo Nordisk
NVO
$252B
| $19.2M | 2.4% |
407,675
+230
| +0.1% | +$10.8K |
|
19
Starbucks
SBUX
$99.6B
| $17.8M | 2.22% |
312,481
-11,257
| -3% | -$640K |
|
20
Henry Schein
HSIC
$8.36B
| $16.9M | 2.11% |
198,243
-920
| -0.5% | -$78.2K |
|
21
Amgen
AMGN
$155B
| $15.7M | 1.97% |
75,925
-520
| -0.7% | -$108K |
|
22
Mettler-Toledo International
MTD
$26.2B
| $14.4M | 1.79% |
23,575
+225
| +1% | +$137K |
|
|
NVRO
23
DELISTED
NEVRO CORP.
NVRO
| $11.1M | 1.39% |
194,470
+21,300
| +12% | +$1.21M |
|
24
AbbVie
ABBV
$373B
| $11.1M | 1.38% |
116,950
-6,750
| -5% | -$638K |
|
|
25
Illinois Tool Works
ITW
$76.2B
| $10.7M | 1.33% |
75,591
+2,415
| +3% | +$341K |
|